Specifically, we wanted to study if NaB treatment can reduce HEY1 and its associated genes’ expression within GBM cell lines, and whether or not this reduction could lead to a reversion of cancer phenotypes (Figure 6). The gene discussed is HEY1; the disease is cancer.